Jean‐Marie Boher

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

Gwénaëlle Gravis, Jean‐Marie Boher, Florence Joly et al. · European Urology · 2015 · 462 citations

Medicine, Oncology, Urology +17

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

Rémy Nicolle, Yuna Blum, Laëtitia Marisa et al. · Cell Reports · 2017 · 196 citations · Full text

Medicine, Cancer Biology, Oncology +17

Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens

Jean‐Robert Delpéro, Philippe Bachellier, Nicolas Régenet et al. · HPB · 2013 · 167 citations · Full text

Medicine, Oncology, Surgery +16

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

Gwénaëlle Gravis, Jean‐Marie Boher, Karim Fizazi et al. · European Urology · 2014 · 130 citations · Full text

Medicine, Oncology, Urology +14

Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients

Jean-Louis Pujol, Jean‐Marie Boher, Jean Grenier et al. · Lung Cancer · 2001 · 128 citations

Medicine, Cancer Biology, Oncology +6